HSPA9 and ovarian benign neoplasm: In contrast, we observed higher abundance of mortalin in the ascites fluid in low (I/II) and advanced (III/IV) stage (p < 0.05 and p < 0.01, respectively, Figure 3e), grade II and III (p < 0.05 and p < 0.01, respectively, Figure 3f), type I and II (p < 0.05 and p < 0.01, respectively, Figure 3g), and endometrioid and serous histology types (p < 0.05 and p < 0.01, respectively, Figure 3h) of OC compared with benign ovarian tumors.